BioXcel share price up – what does it mean?
At April 29, the share price of BioXcel was 46% higher than it was a year before, much better than the market return of around...
Home >
Access the latest news, business developments, company updates, industry trends, events and more.
At April 29, the share price of BioXcel was 46% higher than it was a year before, much better than the market return of around...
Alexion Pharmaceuticals reports that the European Medicines Agency’s Committee for Medicinal Products for Human Use has adopted a positive opinion, recommending marketing authorization for ULTOMIRIS®...
The Connecticut Academy of Science and Engineering has announced that Yale School of Medicine professor Pasko Rakic is the 2019 recipient of the Connecticut Medal...
Hartford HealthCare, Trinity College and the UConn School of Business are planning the launch a medical technology and digital health accelerator, which would join insurance...
Twelve stories above New Haven Harbor, BioXcel Therapeutics is using Big Data technology to mine Big Pharma chemistry and create new drugs that treat pancreatic cancer...
The U.S. Department of Agriculture National Institute of Food and Agriculture has designated UConn’s CEVR (Center of Excellence for Vaccine Research) to be the National Center...
Intensity Therapeutics has received an FDA Fast Track designation for its INT230-6 for the treatment of patients with relapsed or metastatic triple negative breast cancer (TNBC)...
Connecticut is in the top 5 states leading the nation in innovative economies, according to a Bloomberg report. “The state’s defense, aerospace, and biotechnology sectors are...
New therapeutics that harness cellular machinery to degrade targets are entering clinical trials, led by a PROTAC anticancer candidate developed by Arvinas. Whereas most small...
Achillion reports that it achieved threshold enrollment in the Phase 2 trials of ACH-4471 for patients with C3 glomerulopathy (C3G), a devastating disease affecting the...